Viking Therapeutics, Inc. (VKTX) ownership: Top institutional holder: VANGUARD GROUP INC ($351.25M). Insider activity: Net Seller (0 buys, 2 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| VANGUARD GROUP INC | 9984487.00 | $351.25M | 2025-12-31 |
| BlackRock, Inc. | 6880290.00 | $223.88M | 2026-03-31 |
| FMR LLC | 6024753.00 | $196.05M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5012502.00 | $163.11M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4464298.00 | $145.27M | 2026-03-31 |
| TWO SIGMA INVESTMENTS, LP | 4432142.00 | $144.22M | 2026-03-31 |
| STATE STREET CORP | 4395557.00 | $143.03M | 2026-03-31 |
| RAYMOND JAMES FINANCIAL INC | 2075403.00 | $113.51M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-03-10 |
Back to VKTX overview · VKTX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.